We are live on ! Find out more
MG

Meditor Group Portfolio holdings

AUM $48.1M
1-Year Est. Return 38.67%
This Fund
S&P 500
This Quarter Est. Return
+6.19%
1 Year Est. Return
+38.67%
3 Year Est. Return
+41.15%
5 Year Est. Return
+72.2%
10 Year Est. Return
+1,065.64%
AUM
$738M
AUM Growth
–
Cap. Flow
+$747M
Cap. Flow %
101.22%
Top 10 Hldgs %
70.61%
Holding
40
New
40
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
ONXX
ONYX PHARMACEUTICALS INC
ONXX
+$88.6M
2
MRK icon
Merck
MRK
+$87.4M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$74.1M
4
EXEL icon
Exelixis
EXEL
+$56.9M
5
VVUS
Vivus Inc
VVUS
+$54.3M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 43.01%
2 Technology 12.4%
3 Communication Services 11.96%
4 Financials 5.33%
5 Consumer Staples 2.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ECYT
26
DELISTED
Endocyte, Inc. Common Stock
ECYT
$4.4M 0.6%
+335,000
New +$4.52M
NDAQ icon
27
Nasdaq
NDAQ
$51.5B
$4.09M 0.55%
+374,379
New +$3.82M
INFI
28
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$4.05M 0.55%
+250,000
New +$7.74M
NBIX icon
29
Neurocrine Biosciences
NBIX
$17.7B
$3.61M 0.49%
+270,000
New +$3.32M
APC
30
DELISTED
Anadarko Petroleum
APC
$3.61M 0.49%
+42,000
New +$3.62M
MU icon
31
Micron Technology
MU
$1.04T
$3.33M 0.45%
+232,000
New +$2.57M
BAC icon
32
Bank of America
BAC
$435B
$3.14M 0.42%
+244,000
New +$3.11M
RIGL icon
33
Rigel Pharmaceuticals
RIGL
$680M
$3.01M 0.41%
+90,000
New +$4.08M
SQNM
34
DELISTED
SEQUENOM INC NEW
SQNM
$2.95M 0.4%
+700,000
New +$2.8M
VALE icon
35
Vale
VALE
$62.9B
$2.88M 0.39%
+219,400
New +$3.45M
PACD
36
DELISTED
Pacific Drilling S A
PACD
$2.69M 0.36%
+27,500
New +$2.68M
DAL icon
37
Delta Air Lines
DAL
$55.9B
$2.32M 0.31%
+124,000
New +$2.15M
HAL icon
38
Halliburton
HAL
$27.9B
$2.29M 0.31%
+55,000
New +$2.3M
CCL icon
39
Carnival Corporation Ltd
CCL
$36.1B
$1.56M 0.21%
+45,600
New +$1.54M
MSFT icon
40
Microsoft
MSFT
$2.84T
$691K 0.09%
+20,000
New +$655K
1
2

Similar funds

BHCM
Boulder Hill Capital Management New York $47.9M AUM
VMV
Venrock Management VI Palo Alto, California $47.6M AUM 45.26% 1-Year Est. Return
BHH
Baker Hughes Holdings Houston, Texas $47.6M AUM 26.35% 1-Year Est. Return
LAMC
Lubert-Adler Management Company Philadelphia, Pennsylvania $49.3M AUM 17.46% 1-Year Est. Return
MAM
Miria Asset Management St. Julians, Malta $49.9M AUM 21.84% 1-Year Est. Return
BCM
BlueMar Capital Management Miami, Florida $49.9M AUM 28.76% 1-Year Est. Return
LOF
Lightspeed Opportunity Fund Menlo Park, California $50.1M AUM 53.1% 1-Year Est. Return
CLCM
Center Lake Capital Management West Palm Beach, Florida $45.8M AUM 58.23% 1-Year Est. Return

Meditor Group's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Meditor Group, which disclosed 40 positions worth $738M. Its ten largest holdings account for 71% of the portfolio.

Its largest position is ONYX PHARMACEUTICALS INC: 962,103 shares worth $83.5M.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, followed by Technology and Communication Services.

  • Meditor Group's largest Q2 2013 buy was ONYX PHARMACEUTICALS INC: 962,103 shares worth $83.5M.
  • Meditor Group's ten largest holdings make up 71% of its $738M portfolio in Q2 2013.
  • Meditor Group disclosed 40 positions in Q2 2013, its first 13F filing on record.

Based on Meditor Group's 13F filing for Q2 2013, filed 29 Jul 2013.